 Home > Active Ingredient News > Immunology News > Arthritis Rheumatol: Pregnancy outcomes in women with psoriatic arthritis are related to anti-rheumatic treatment and timing

Arthritis Rheumatol: Pregnancy outcomes in women with psoriatic arthritis are related to anti-rheumatic treatment and timing

 Last Update: 2021-11-01
 Source: Internet
 Author: User

Tags

signs preeclampsia pregnancy

baby pregnancy stages

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, a research article was published in Arthritis & Rheumatology, an authoritative journal in the field of rheumatic immunology , which aims to evaluate pregnancy outcomes related to anti-rheumatic treatment before and during pregnancy

immunity

The 2007-2017 Swedish national register-based cohort study included 921 psoriatic arthritis (PsA) pregnancies and 9210 non-PSA pregnancies (matched by 1:10 maternal age, year, and parity)

Compared with non-PsA pregnancy, women with PsA are more obese, smoke more often, and are more often diagnosed with pre-pregnancy hypertension and diabetes

Diagnose diabetes

The risk varies according to the existence, timing and type of anti-rheumatic treatment.

It can be seen that compared with non-PsA pregnancy, the risk of premature delivery and cesarean section is mostly increased in people who receive anti-rheumatic treatment (especially biologics) during pregnancy

Compared with non-PsA pregnancies, the risk of premature delivery and cesarean section is mostly increased in people who receive anti-rheumatic treatments (especially biologics) during pregnancy

Original source:

Katarina Remaeus,et al.

Pregnancy outcomes in women with psoriatic arthritis with respect to presence and timing of antirheumatic treatment

in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.